Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality

Comprehensive methylome sequencing reveals prognostic epigenetic biomarkers for prostate cancer mortality

Abstract Background Prostate cancer is a clinically heterogeneous disease with a subset of patients rapidly progressing to lethal‐metastatic prostate cancer. Current clinicopathological measures are imperfect predictors of disease progression. Epigenetic changes are amongst the earliest molecular ch...

Full description

Bibliographic Details
Main Authors: Ruth Pidsley, Dilys Lam, Wenjia Qu, Timothy J. Peters, Phuc‐Loi Luu, Darren Korbie, Clare Stirzaker, Roger J. Daly, Phillip Stricker, James G. Kench, Lisa G. Horvath, Susan J. Clark
Format: Article
Language:English
Published: Wiley 2022-10-01
Series:Clinical and Translational Medicine
Subjects:
biomarkers
CACNA2D4
DNA methylation
prognosis
prostate cancer
survival
Online Access:https://doi.org/10.1002/ctm2.1030

Internet

https://doi.org/10.1002/ctm2.1030

Similar Items